162 related articles for article (PubMed ID: 33720741)
1. Symptomatic hypomagnesemia induced by proton-pump inhibitors (PPIs). A known adverse event that is worth recalling.
Keco Huerga A; García de la Borbolla Serres J; Castro Fernández M
Rev Esp Enferm Dig; 2021 Oct; 113(10):728-729. PubMed ID: 33720741
[TBL] [Abstract][Full Text] [Related]
2. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
[TBL] [Abstract][Full Text] [Related]
3. Hypomagnesemia and proton-pump inhibitors.
Famularo G; Gasbarrone L; Minisola G
Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
Luk CP; Parsons R; Lee YP; Hughes JD
Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
[TBL] [Abstract][Full Text] [Related]
5. The association of proton pump inhibitors and hypomagnesemia in the community setting.
Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
[TBL] [Abstract][Full Text] [Related]
6. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
[TBL] [Abstract][Full Text] [Related]
7. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.
Furlanetto TW; Faulhaber GA
Arch Intern Med; 2011 Aug; 171(15):1391-2. PubMed ID: 21555654
[TBL] [Abstract][Full Text] [Related]
8. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.
Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP
Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584
[TBL] [Abstract][Full Text] [Related]
9. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
Semb S; Helgstrand F; Hjørne F; Bytzer P
World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234
[TBL] [Abstract][Full Text] [Related]
10. Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic.
Uehara A; Kita Y; Sumi H; Shibagaki Y
Intern Med; 2019 Aug; 58(15):2201-2205. PubMed ID: 30996187
[TBL] [Abstract][Full Text] [Related]
11. Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia.
Chrysant SG; Chrysant GS
Expert Opin Drug Saf; 2020 Jan; 19(1):59-67. PubMed ID: 31795777
[No Abstract] [Full Text] [Related]
12. The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV.
Sutton SS; Magagnoli J; Cummings T; Hardin JW
J Int Assoc Provid AIDS Care; 2019; 18():2325958218821652. PubMed ID: 30798693
[TBL] [Abstract][Full Text] [Related]
13. Hypomagnesemia associated with a proton pump inhibitor.
Matsuyama J; Tsuji K; Doyama H; Kim F; Takeda Y; Kito Y; Ito R; Nakanishi H; Hayashi T; Waseda Y; Tsuji S; Takemura K; Yamada S; Okada T; Kanaya H
Intern Med; 2012; 51(16):2231-4. PubMed ID: 22892510
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
[TBL] [Abstract][Full Text] [Related]
15. [Severe hypomagnesaemia due to proton pump inhibitor use].
van den Berg S; Scheer MLJ; Holman ND
Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626
[TBL] [Abstract][Full Text] [Related]
16. Serum magnesium and proton-pump inhibitors use: a cross-sectional study.
Faulhaber GA; Ascoli BM; Lubini A; Mossmann M; Rossi G; Geib G; Furlanetto TW
Rev Assoc Med Bras (1992); 2013; 59(3):276-9. PubMed ID: 23680271
[TBL] [Abstract][Full Text] [Related]
17. Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis.
Liao S; Gan L; Mei Z
Medicine (Baltimore); 2019 Mar; 98(13):e15011. PubMed ID: 30921222
[TBL] [Abstract][Full Text] [Related]
18. [Atrial fibrillation and QT prolongation due to proton pump inhibitor-induced hypomagnesemia].
Noirclerc N; Delfanne C; Dompnier A
Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):201-203. PubMed ID: 32800318
[TBL] [Abstract][Full Text] [Related]
19. Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review.
William JH; Danziger J
J Clin Pharmacol; 2016 Jun; 56(6):660-8. PubMed ID: 26582556
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies.
Srinutta T; Chewcharat A; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Jaber BL; Susantitaphong P
Medicine (Baltimore); 2019 Nov; 98(44):e17788. PubMed ID: 31689852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
